| CRC | colorectal cancer |
| CEA | carcinoembryonic antigen |
| EVs | extracellular vehicles |
| MVBs | multivesicular bodies |
| miRNAs | micro-RNAs |
| UTR | untranslated region |
| GOFs | gain of oncogenic functions |
| FU | 5-fluorouracil |
| TME | tumor microenvironment |
| CAFS | cancer-associated fibroblasts |
| ECM | extracellular matrix constituents |
| TGF β | transforming growth factor β |
| PDGF | platelet derive growth factor |
| MCP1 | monocyte chemotactic protein 1 |
| IGF | insulin-like growth factor |
| FGF-2 | fibroblast growth factor 2 |
| PGE | prostaglandin E |
| ROS | reactive oxygen species |
| MDSC | myeloid-derived suppressor cells |
| TREG–T | regulatory cells |
| Th2 | type 2 helper |
| uPA | urokinase-type plasminogen activator |
| ADM | adrenomedullin |
| MMPs | matrix metalloproteinases |